CAB-LA HIV prevention jab's quiet exit as LEN arrives
CAB-LA, the two-monthly HIV prevention injection, was approved in South Africa over three years ago but never reached government clinics. As lenacapavir prepares to launch, CAB-LA's quiet exit carries lessons about what it takes to turn good science into public health. The post CAB-LA: The prevention jab that never had its moment, and what it leaves behind as LEN arrives appeared first on Bhekisisa.